Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jun;90(6):769-72.
doi: 10.1136/bjo.2005.087486. Epub 2006 Feb 17.

Expression of insulin-like growth factor binding protein-3 in pterygium tissue

Affiliations

Expression of insulin-like growth factor binding protein-3 in pterygium tissue

Y W Wong et al. Br J Ophthalmol. 2006 Jun.

Abstract

Background: Pterygium is a fibrovascular overgrowth from the conjunctiva onto the cornea. The pathogenesis of this common ocular surface disorder is not well understood and the only treatment is surgical removal.

Methods: DNA microarray analysis of primary pterygium tissue was carried out using uninvolved conjunctiva tissue as a comparison for gene expression levels. Real time polymerase chain reaction (PCR) was used to verify the mRNA level of expression for genes changed in pterygium. Western blot analysis and immunohistochemistry showed protein expression levels and the tissue distribution.

Results: Microarray analysis revealed that mRNA levels of a number of genes were changed in primary pterygium. In particular the gene for insulin-like growth factor binding protein-3, (IGFBP3), which modulates the effects of insulin-like growth factor on cells was significantly decreased. Both the message and protein expression of IGFBP3 in pterygium were decreased compared to normal, uninvolved conjunctiva.

Conclusion: Decreased levels of IGFBP3 protein have been strongly correlated with the presence of cancer. Identification of the low level of expression of IGFBP3 in pterygium suggests that the pathway controlling cell proliferation has lost an important control mechanism, which may explain the continued growth of pterygium.

PubMed Disclaimer

Comment in

  • Pterygium.
    Solomon AS. Solomon AS. Br J Ophthalmol. 2006 Jun;90(6):665-6. doi: 10.1136/bjo.2006.091413. Br J Ophthalmol. 2006. PMID: 16714259 Free PMC article.

References

    1. Coroneo M T, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 199910282–288. - PubMed
    1. Cameron M E. Histology of pterygium: an electron microscopic study. Br J Ophthalmol 198367604–608. - PMC - PubMed
    1. Di Girolamo N, Chui J, Coroneo M T.et al Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 200423195–228. - PubMed
    1. Solomon A, Grueterich M, Li D Q.et al Overexpression of Insulin‐like growth factor‐binding protein‐2 in pterygium body fibroblasts. Invest Ophthalmol Vis Sci 200344573–580. - PubMed
    1. Van Kleffens M, Groffen C A, Dits N F.et al Generation of antisera to mouse insulin‐like growth factor binding proteins (IGFBP)‐1 to ‐6: comparison of IGFBP protein and messenger ribonucleic acid localization in the mouse embryo. Endocrinology 19991405944–5952. - PubMed

Publication types

MeSH terms

Substances